financetom
Business
financetom
/
Business
/
Japan's Sumitomo Metal forecasts larger global nickel supply surplus in 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Japan's Sumitomo Metal forecasts larger global nickel supply surplus in 2025
Apr 7, 2025 10:56 PM

TOKYO, April 8 (Reuters) - The global nickel market is

expected to see a larger surplus this year due to continued

production expansion in Indonesia, Japan's largest nickel

smelter Sumitomo Metal Mining ( STMNF ) said on Tuesday.

The surplus is projected at 215,000 metric tons in 2025,

compared to 173,000 tons last year as Indonesia's output of

low-grade nickel pig iron is expected to rise 5.7% to 1.62

million tons, SMM said during its half-year market outlook

presentation.

Global nickel demand is forecast to grow 3.2% year-on-year

to 3.42 million tons this year, while supply is likely to

increase 4.3% to 3.64 million tons, SMM said.

The forecast does not factor in potential impact from U.S.

tariffs as it is difficult to predict, SMM Executive Officer

Yusuke Niwa said.

"But there is a risk that global demand could weaken if the

U.S. economy slows, affecting demand for nickel-based special

alloys used in aircraft engines," Niwa said.

Nickel is primarily used in stainless steel, but is also a

key component in lithium-ion batteries that power electric

vehicles (EVs), where demand was expected to grow.

However, growth is slowing as lithium-iron-phosphate (LFP)

batteries, which are cheaper than nickel-rich alternatives,

gained market share, Niwa said.

LFP batteries have become the rising stars of the industry,

accounting for two-thirds of all EV sales in China in 2023,

according to the International Energy Agency.

These batteries rely solely on lithium as a critical metal,

requiring neither nickel or cobalt, making them more

cost-effective and environmentally friendly than other battery

chemistries.

SMM, which supplies cathode materials for the Panasonic ( PCRFF )

lithium-ion batteries used in Tesla EVs,

predicted that global nickel demand for batteries will rise to

around 480,000 tons in 2025, up only 10,000 tons from 2024.

(Reporting by Yuka Obayashi; Editing by Varun H K)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Ford pulls guidance, warns it will take $1.5 billion hit from Trump's tariffs
Ford pulls guidance, warns it will take $1.5 billion hit from Trump's tariffs
May 26, 2025
DETROIT (Reuters) -Ford Motor ( F ) suspended its annual guidance on Monday because of uncertainty around U.S. President Donald Trump's tariffs, saying the levies would cost the company about $1.5 billion in adjusted earnings before interest and taxes. In February, the Dearborn, Michigan automaker projected earnings before interest and taxes of $7.0 billion to $8.5 billion for 2025. That...
Ocular Therapeutix (OCUL) Stock Drops 13% After Q1 Earnings
Ocular Therapeutix (OCUL) Stock Drops 13% After Q1 Earnings
May 26, 2025
Ocular Therapeutix Inc ( OCUL ) shares are trading lower by 13.3% to $7.63 Monday afternoon after the company reported worse-than-expected first-quarter financial results. What To Know: Ocular Therapeutix ( OCUL ) reported first-quarter 2025 results that missed analyst expectations on both earnings and revenue. The company posted a net loss of 38 cents per share, wider than the consensus estimate of...
Vertex misses quarterly results on weaker-than-expected demand for cystic fibrosis drug
Vertex misses quarterly results on weaker-than-expected demand for cystic fibrosis drug
May 26, 2025
May 5 (Reuters) - Vertex Pharmaceuticals ( VRTX ) missed Wall Street estimates for quarterly results on Monday, due to lower-than-expected sales of its cystic fibrosis (CF) drug Trikafta. However, the drugmaker raised the lower end of its revenue forecast as it looks to its acute pain drug, Journavx, and newer CF drugs to drive growth beyond its established line...
Copyright 2023-2026 - www.financetom.com All Rights Reserved